Loading...
NAD Market Competition And Regulatory Risks Will Challenge Margins Yet Support Long-Term Healthy Aging Demand
AN
AnalystLowTarget
Not Invested
Community Contributor
Published
14 Dec 25
Views
76
14 Dec
US$3.83
AnalystLowTarget's Fair Value
US$12.00
68.1% undervalued intrinsic discount1Y
-65.1%7D
2.1%1Y
-65.1%7D
2.1%You can edit this narrative until Dec 15 11:05 AM. Then, changes will post as Updates.
Author's Valuation
US$1268.1% undervalued intrinsic discount
AnalystLowTarget Fair Value